Previous reports have revealed that Prospero-related homeobox 1 (Prox1) is required for the migration and differentiation of hepatoblasts during embryonic liver formation. However, the role of Prox1 in adults remains to be elucidated. We created liver-specific Prox1 knockout mice to verify the role of Prox1 in adult hepatocytes. The mutant mice exhibit hepatic injury and a nonobese, insulin-resistant diabetic phenotype in vivo. Hepatocyte injury is observed predominantly in the perivenous region and is characterized by the formation of vacuoles and emergence of round-shaped mitochondria, suggesting that the effect of Prox1 on the maintenance of adult hepatocytes is region dependent. Furthermore, glycolysis is suppressed, and both oxidative phosphorylation and autophagy are upregulated in the livers of Prox1 knockout mice, indicating that Prox1 has a role in regulating energy homeostasis in hepatocytes.
Type 2 diabetes is a disease caused by the insulin resistance of peripheral tissues/organs such as fat, muscle, and liver. Recent advances in our understanding of the genetic susceptibility to type 2 diabetes include singlenucleotide polymorphisms (SNPs) of several genes. Prospero-related homeobox 1 (Prox1) plays pivotal roles in the embryonic formation of several organs and tissues including liver, pancreas, eye, lymphatic vessel, nerve, and cardiac muscle in mice [1] [2] [3] [4] and a metaanalysis of a genome-wide association study revealed that the rs340874 SNP in the PROX1 gene is associated with type 2 diabetes [5] . Another report showed that people who carry this variance are more glucose intolerant and have more visceral fat than people without it [6] . Harvey et al. [7] reported an animal model in which Prox1 heterozygous adult mice become obese and had higher serum insulin levels and hepatic lipid accumulation. While the same group demonstrated that pancreas-specific Prox1 inactivation did not cause the diabetic phenotype in mice [8] , obesity is likely the main mechanism of insulin resistance in both Prox1 heterozygous mice and patients who carry the rs340874 SNP in PROX1. Indeed, Prox1 is expressed in adipose tissues in human, with expression higher in omental adipose tissue than in subcutaneous adipose tissue [9] . However, the involvement of hepatic Prox1
should not be neglected, since liver is the largest target organ of insulin effect.
The role of Prox1 in liver has been extensively analyzed during embryogenesis. During liver organogenesis, Prox1 is first expressed at embryonic day 8.5 (E8.5) in the endodermal cells of mice [10] , and its global inactivation impairs the migration of hepatoblasts to cause hypomorphic liver formation [11] . On the other hand, there is only limited information on the role of Prox1 in adult liver. Several in vitro experiments showed that Prox1 negatively regulates mitochondrial function through its physical association with peroxisome proliferator-activated receptor gamma coactivator 1-alpha [12] and that Prox1 downregulation by siRNA upregulates phosphoenolpyruvate carboxykinase (PEPCK) [13] , indicating its role in controlling the energy metabolism of hepatocytes. Despite these in vitro studies, the involvement of hepatic Prox1 in the pathogenesis of type 2 diabetes has not been clarified in vivo.
In this study, we used Albumin-Cre mice to inactivate Prox1 in a liver-specific manner and analyzed the liver phenotype and glucose homeostasis in the adult stage. As expected, the mutant mice exhibited insulin-resistant diabetic phenotype in vivo without obesity. Blood examination showed hepatic dysfunction characterized by elevated transaminase, bilirubin, and lower albumin. Histologically, hepatocyte injury was characterized by the formation of vacuoles and the emergence of roundshaped mitochondria. Interestingly, the degree of hepatocyte injury was more severe in the perivenous region than periportal region, suggesting a region-specific dependency on Prox1 effects in adult liver. As for the energy metabolism in hepatocytes, glycolysis was suppressed and autophagy was stimulated, suggesting energy starvation in the perivenous region. We also provide evidence that upregulated oxidative phosphorylation (OXPHOS) in mitochondria and excess reactive oxygen species (ROS) generation resulted in hepatocyte injury and histological disorganization in the perivenous region. These results indicate a pivotal role of Prox1 in maintaining the energy homeostasis of adult hepatocytes and its involvement in the pathogenesis of type 2 diabetes.
Materials and methods

Mice
Prox1-floxed mice were generated by Unitech, Co. (Kashiwa, Japan). Mutant mice were produced on a C57BL/6J background. A neo-loxP cassette carrying the phosphoglycerate kinase promoter-driven neomycin-resistance gene flanked by FRT sequences was inserted into intron 2 of the Prox1 gene. 
Genotyping
Genomic DNA from the tail tips of the mice was genotyped by PCR with the primer sets (Prox1 forward) 5 0 -CTAGGTCTCCCAAGATACTCAGATG-3 0 and (Prox1
The product sizes were 534 and 753 bp from WT and KO alleles, respectively.
Tissue preparation
Tissue preparation was performed as previously described with some modification [15] . Briefly, the fixative solution (PBS containing 4% PFA; for X-gal staining, 2% glutaraldehyde was further added) was perfused when the specimens were prepared for X-gal staining, hematoxylin and eosin staining, periodic acid-schiff (PAS) staining or immunofluorescence. For the immunohistochemistry of 8-OHdG, fresh liver was cut into 3-mm-thick pieces without perfusion and immersed in Bouin solution (Wako Pure Chemical, Osaka, Japan) overnight. Finally, the specimens were embedded in paraffin.
Immunohistochemistry and immunofluorescence
Paraffin sections were cut into 3-lm-thick slices. The immunohistochemistry of 8-OHdG was performed as previously described with some modification [16] . After deparaffinization and hydration, the antigen retrieval procedure was performed with Target Retrieval Solution pH 6.0 (Dako, Glostrup, Denmark) in accordance with the manufacturer's instructions. Peroxidase blocking was done with 1% peroxidase diluted with methanol for 30 min. The sections were incubated for 30 min at room temperature with Protein block (Dako), then incubated with primary antibody overnight at 4°C. Sections were treated according to the protocol of the VECTASTAIN ABC kit (Vector Laboratories, Burlingame, CA, USA) and DAB Peroxidase Substrate (Vector Laboratories). Immunofluorescence and X-gal staining was performed as previously reported [15, 17] . After the antigen retrieval procedure, the sections were incubated overnight at 4°C with primary antibodies (Table S1 ). The sections were then washed in PBS and incubated for 60 min with secondary antibodies (Table S2 ). For the immunofluorescence of light chain 3B (LC3B), fresh frozen liver was cut into 6-lm-thick slices and immersed in ice-cold 100% methanol for 10 min. The process after the antigen retrieval procedure was the same as the other immunofluorescence technique. Images were visualized using HS All-in-one Fluorescence Microscopy BZ-9000E (Keyence, Osaka, Japan).
Electron microscopy
The fixation of liver samples was performed as previously reported with some modification [18] . Briefly, we used PBS containing 4% PFA and 2% glutaraldehyde as the fixative solution. Sections were observed by transmission electron microscopy, Hitachi H-7650 (Hitachi, Tokyo, Japan).
RNA isolation and RT-PCR
Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germany). First-strand cDNA synthesis was performed using ReverTra Ace qPCR RT Master Mix (Toyobo, Osaka, Japan). Quantitative RT-PCR was performed with TaqMan. The mouse primer and probe sequences are listed in Table S3 [19, 20] . Independent experiments were performed three times and confirmed. Data were normalized in relation to the expression of beta-2 microglobulin. The mouse beta-2 microglobulin, human Prox1, and human beta-2 microglobulin probes used were TaqMan Gene Expression Assay no. Mm00437762, Hs00896294, and Hs00984230, respectively (Applied Biosystems, Foster City, CA, USA). The analysis was performed using a standard curve (mouse primers) and comparative CT methods (primers for human).
Western blot
Liver tissues were lysed in RIPA buffer (Wako Pure Chemical) in the presence of protease inhibitor (Roche, Basel, Switzerland). Obtained samples were electrophoresed in 10% SDS/PAGE gels and transferred to polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA). Membranes were blocked with 5% skim milk in TBS-T and incubated with 1 : 500 dilution of anti-Prox1 antibody (Proteintech, Rosement, IL, USA), 1 : 1000 dilution of anti-LC3B antibody (CST, Danvers, MA, USA), or 1 : 5000 dilution of anti-bactin antibody (Sigma Aldrich, St. Louis, MO, USA) overnight at 4°C. After washing, the membranes were reacted with HRP-linked secondary antibodies (GE Healthcare, Chicago, IL, USA) at 1 : 5000 dilution. Chemiluminescence was detected with ECL Prime Western Blotting Detection Reagent (GE Healthcare) and visualized with ImageQuant LAS-4000 (GE Healthcare). The intensity of the bands was quantified with imaging analysis software, IMAGEJ (National Institute of Health in USA) using b-actin as an internal control.
Blood examination
Blood was centrifuged, and serum was submitted to SRL Inc., Japan for analysis.
Intraperitoneal glucose tolerance test and insulin ELISA
Intraperitoneal glucose tolerance test (IPGTT) and insulin ELISA were performed as previously described [21] .
siRNA and extracellular flux analysis
Knockdown experiments were performed as previously described with some modification [12] . We used the Hep3B cell line cultured in Dulbecco's Modified Eagle Medium (Sigma Aldrich) supplemented with 10% FBS and penicillin/ streptomycin. Hep3B cells were transfected shortly after seeding with either Stealth RNAiÒ Negative Control Duplex (Invitrogen, Carlsbad, CA, USA) or ON-TARGETplus Human PROX1 siRNA -SMARTpool (Dharmacon, Lafayette, CO, USA) using HiPerfect reagent (Qiagen). Fortyeight hours after transfection, the cells were treated with Accutase (ICT, San Diego, CA, USA), counted and seeded at 20 000 cells/well in XFe96-well plates (Seahorse Bioscience, North Billerica, MA, USA). Twenty-four hours after reseeding, the plates were washed and incubated for 1 h in a 37°C incubator under air in 175 mL of assay medium (Seahorse Bioscience) supplemented with 2 mM Glutamine and pH adjusted to 7.4. We used Glycolysis Stress Test Kit (Seahorse Bioscience) with glucose (final concentration 10 mM), oligomycin (final concentration 1 mM), and 2-Deoxy-D-glucose (final concentration 50 mM) added sequentially, and the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) at each time point were averaged from 6 to 10 wells. Experiments were performed in triplicate.
Statistical analysis
All indices were analyzed using an unpaired Student's t test (two-tailed). P < 0.05 was considered significant.
Results
Creation of liver-specific Prox1 knockout mice
To make liver-specific Prox1 knockout mice, we created Prox1-floxed mice, in which exon 2 is flanked by the loxP sequence (Fig. 1A) , and crossbred the mice with Albumin-Cre transgenic mice. The expression level of Prox1 mRNA in the liver showed no significant difference among Albumin-Cre mice (control mice), Prox1-floxed mice and wild-type mice (Fig. 1D) , and we observed no abnormal phenotype in these mice. Non-specific Cre recombination was not detected in other tissues/organs including pancreas, skeletal muscles, subcutaneous adipose tissues, and omental adipose tissues, as judged by lineage-tracing experiments in mice crossed with Rosa26R mice, confirming the specificity of AlbuminCre (Fig. S1 ). Consistent with a previous report that used the same Albumin-Cre and different Prox1-floxed strains [22] , qPCR analyses showed 90% reduction in hepatic Prox1 expression without apparent histological phenotype at embryonic day 18.5 (E18.5) in our Prox1cKO mice (data not shown). At P42, Prox1 expression was detected in very few hepatocytes and cholangiocytes in Prox1cKO mice (Fig. 1B right panel) . Quantitatively, Prox1 protein and mRNA levels were approximately 16% and 15% those of control mice, respectively (Fig. 1C,D) .
Nonobese glucose intolerance due to hepatic insulin resistance in Prox1cKO mice
Mutant mice had normal appearance, body weight consistent with control mice during postnatal stages, and no abnormal subcutaneous or visceral fat The relative mRNA expression level of Prox1 in the liver showed no significant difference in control mice, Prox1-floxed mice and wild-type mice (Prox1cKO mice, n = 4; control mice, n = 4; Prox1-floxed mice, n = 4; wild-type mice, n = 4). Scale bars = 20 lm. *P < 0.05. **P < 0.01. Bars represent the mean value AE SE. accumulation ( Fig. 2A,B) . Furthermore, their blood glucose level was comparable to control mice both in the feeding period and after starvation (Table 1) . However, the IPGTT revealed that the mutant mice are glucose intolerant (Fig. 2C ). In addition, serum insulin levels at 15 min after glucose challenge were significantly higher (Fig. 2D) , suggesting peripheral insulin resistance in Prox1cKO mice.
Blood examination indicated hepatocyte injury and impaired liver function in Prox1cKO mice
Blood examination revealed Prox1cKO mice exhibited hepatic dysfunction (Fig. 3) . While lactate dehydrogenase (LDH) did not show significantly different levels, aspartate transaminase (AST) and alanine transaminase (ALT) were significantly higher in Prox1cKO mice, Plasma insulin concentrations at 15 min after glucose challenge in Prox1cKO mice (red, n = 6) and control mice (blue, n = 6). *P < 0.05. **P < 0.01. Bars represent the mean value AE SE.
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Tissue structural impairment and ectopically hyperactivated mitochondria in perivenous region
We next performed histological analysis. While the lining of the hepatocytes in the periportal region was normal, it became irregular in the perivenous region (Fig. 4A) . High magnification revealed that the perivenous hepatocytes contained abundant vacuoles in the cytoplasm, but these were not lipid droplets, as judged by negative staining with Oil-red-O (data not shown).
Immunostaining for laminin and in vivo angiographic imaging using dextran-conjugated fluorescence revealed irregular and distorted structures of the sinusoids and blood vessels predominantly in the perivenous region (Fig. S2) . We speculate that the irregular structures of the hepatocytes and vessels were secondary effects caused by the developing hepatocyte injury in the perivenous region, since very few vacuoles were detected and no apparent structural impairment was observed at younger stages (around P10; data not shown).
We noticed phenotypic changes in the mitochondria by electron microscopy analysis; in control mice, mitochondria of the periportal region were round-shaped with high electron density but elongated in the perivenous region, while in Prox1cKO mice the mitochondria were round-shaped and had higher electron density in both regions (Fig. 4B) . That is, in Prox1cKO mice, Blood glucose levels of Prox1cKO mice and control mice after 16 h of starvation or ad libitum feeding showed no significant difference (Prox1cKO mice, n = 6; control mice, n = 6). Fig. 3 . Hepatocyte injury and defective liver function in Prox1cKO mice. Blood examination of Prox1cKO mice and control mice (Prox1cKO mice, n = 4; control mice, n = 4). AST, ALT, T-Bil and D-Bil were higher in the blood of Prox1cKO mice, albumin was lower, and LDH showed no change. *P < 0.05. **P < 0.01. Bars represent the mean value AE SE. mitochondria in the perivenous region took a phenotype consistent of periportal mitochondria. Considering that OXPHOS is more active in the periportal region of normal liver [23] [24] [25] , the phenotypic impairment of mitochondria in the perivenous region suggested ectopically hyperactivated OXPHOS that presumably lead to hepatocyte injury. Consistently, we observed 8-hydroxy-2 0 -deoxyguanosine (8-OHdG)-positive hepatocytes in this region (Fig. 4C) , indicating DNA damage due to excess ROS generation.
Activated autophagy in the perivenous region of Prox1cKO liver
Electron microscopy analysis identified autophagosomes and autolysosomes, with the former being confirmed by the positive immunostaining of LC3B (Fig. 5A,B) . The ratio of LC3B-II/LC3B-I expression was twofold that of control mice, indicating upregulated autophagy in Prox1cKO liver (Fig. 5C) . 
Reduced glycolysis activity by Prox1 inactivation
Ectopically hyperactivated mitochondria and upregulated autophagy in the perivenous region led us to hypothesize that hepatocytes were unable to meet the energy demands of mutant liver. This notion prompted us to analyze the expression levels of glucose metabolism enzymes in the liver. We found that glucokinase (Gck) was decreased and Pepck and glucose 6-phosphatase (G6Pase) were increased, suggesting reduced glycolysis activity and increased gluconeogenic activity in mutant hepatocytes (Fig. 6A) . Additionally, the amount of hepatic glycogen storage was decreased in mutant mice (Fig. 6B) . These results are consistent with previous studies, which reported that both liver-specific GCK knockout mice and liver-specific G6Pase overexpressing mice had less hepatic glycogen storage [26, 27] .
We next carried out siRNA-based knockdown experiments using the Hep3B cell line to evaluate the role of Prox1 in the energy metabolism of hepatocytes. We confirmed the knockdown efficiency by western blot and qRT-PCR analysis (Fig. 6C,D) . Extracellular flux analysis revealed a significantly declined ECAR, indicating decreased glycolysis in siPROX1-treated cells (Fig. 6E) . In addition, OCR was increased upon glucose stimulation, suggesting stimulated OXPHOS activity.
Discussion
It is well known that obesity and hepatic injury are the main cause of human type 2 diabetes. In this report, we demonstrated that liver-specific Prox1 knockout mice exhibited glucose intolerance without obesity, and that mutant mice showed hepatic injury associated with hyperactivated OXPHOS and excess ROS production. Furthermore, we provide evidence that Gck was downregulated and Pepck and G6Pase were upregulated in Prox1cKO hepatocytes, indicating that Prox1 controls the balance of glycolysis and gluconeogenesis activities in hepatocytes. Previously, Harvey et al. [7] reported that adult Prox1 heterozygous mice exhibit a glucose intolerance that is associated with obesity and hepatic lipid accumulation. They proposed a model where the impaired formation of lymphatic vessels caused obesity that induced an elevation of blood insulin and leptin levels leading to glucose intolerance. Since lipid metabolism was normal in the liver, they speculated that hepatic lipid accumulation was secondary to the obesity in Prox1 heterozygous mice.
While the involvement of hepatic lipid accumulation in glucose intolerance was not stressed in the Prox1 heterozygous model, recent reports have revealed a connection between obesity induced, progressive hepatic lipid accumulation and type 2 diabetes in humans where mitochondrial function played an important role. Liver biopsies from obese diabetic patients with nonalcoholic fatty liver (NAFLD) or steatohepatitis (NASH) showed progressive lipid accumulation causes mitochondrial stress [28, 29] . In NAFLD, the hepatic lipid accumulation was relatively mild such that hepatic mitochondria could adapt by increasing maximal respiration rates. However, the hepatic lipid accumulation was higher in NASH such that the hepatic adaptation collapsed and excess ROS production and hepatocyte injury occurred. Similarly, in our liver-specific Prox1 knockout mice, abnormally activated OXPHOS caused excess ROS and hepatocyte injury. However, our liver-specific Prox1 knockout mice did not show obesity or hepatic fatty change, suggesting that the underlying mechanism for insulin resistance differs from that in heterozygous mutant mice. Postic et al. [30] reported that liver-specific GCK knockout mice show hyperinsulinemic hyperglycemia. In addition, While it is unclear whether hepatic injury was observed in these mice, these findings are consistent with our Prox1cKO hepatocytes. Overall, these results indicate that an unbalanced glucose metabolism in the liver could contribute to insulin resistance.
Prox1cKO mice showed liver dysfunction and abrogated histological appearances predominantly in the perivenous region. The hepatocyte lining is divided into three zones: periportal hepatocytes (zone 1), intermittent cells (zone 2), and perivenous hepatocytes (zone 3), and previous reports have shown zone-dependent hepatic function where cells preserve an optimal balance of the glycolytic pathway and OXPHOS to meet energy demands [23, 24] . In periportal hepatocytes, OXPHOS plays a larger role in the cellular energy supply, and these cells release glucose into the blood stream by gluconeogenesis upon starvation. In contrast, perivenous hepatocytes, which have lower oxygen concentration than periportal hepatocytes, express more Gck to conduct more glycolysis [32] . Although immunohistochemical analyses showed no apparent difference in the amount of expressed Prox1 among zones 1-3 (data not shown), the reduced glycolysis may explain well the zone 3-dominant hepatocyte injury in Prox1cKO mice. Consistently, qRT-PCR analysis showed less Gck expression in the mutant liver and Prox1 knockdown experiments in vitro demonstrated attenuated ECAR, demonstrating Prox1 inactivation suppressed glycolysis activity both in vivo and in vitro. Hepatocytes in zone 3, whose energy supply mainly depends on glycolysis, would be subjected to energy starvation by the reduced glycolysis activity in Prox1cKO mice. Along this scenario, the cells may compensate by stimulating autophagy and activating OXPHOS to meet their energy demand, but this response also resulted in excess ROS production, leading to hepatocyte injury. The relative expression levels of Gck, Pepck, and G6Pase in the liver of Prox1cKO mice were approximately 50%, 741%, and 150%, respectively, those of control mice. (Prox1cKO mice, n = 4; control mice, n = 4). (B) PAS staining shows decreased glycogen storage in the liver of Prox1cKO mice. (C) The relative PROX1 protein expression level in Hep3B cells treated with PROX1 siRNA was about 15% that in Hep3B cells treated with CONTROL siRNA (siPROX1, n = 3; siCONTROL, n = 3). (D) The relative PROX1 mRNA expression level in Hep3B cells treated with PROX1 siRNA was almost 30% that in Hep3B cells treated with CONTROL siRNA (siPROX1, n = 3; siCONTROL, n = 3). (E) Extracellular Flux Analysis. Hep3B cells treated with PROX1 siRNA (red, n = 3) showed a significantly lower ratio of ECAR and significantly higher ratio of OCR after glucose challenge than Hep3B cells treated with CONTROL siRNA (blue, n = 3). P, portal vein. C, central vein. Scale bars = 100 lm, *P < 0.05. **P < 0.01. Bars represent the mean value AE SE.
liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. 
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